U.S. Senator Chris Coons released the following statement after AstraZeneca announced it was cutting 1,200 jobs -- overwhelmingly research and development positions -- in its Wilmington headquarters.
"This is a disappointing day for Delaware, and devastating news for the 1,200 AstraZeneca employees and their families affected by this decision. Delawareans will stand with our neighbors during this challenging time, and I am committed to doing whatever I can to help them through it. I have spoken with AstraZeneca's leadership and will continue to advocate on behalf of those impacted by this decision. Our talented workforce has long made Delaware a destination for companies doing advanced research, and it is my hope that some of these positions will find their way back home to Delaware soon. There is a wide array of innovative companies doing high-end research that could really benefit from the enormously talented scientists and researchers now looking for work."